Six-day-old TH-MYCN+/+ mice were treated with intraperitoneal vehicle controls, vincristine (0.05 mg/kg/day), or barasertib (25 mg/kg/day) for 4 days per week over 5 weeks, and thereafter assessed for tumor growth. This evidence concerns the gene MYCN and neoplasm.